Pfizer Vitiligo Study B7981019
Published by:
Tissue Analytics
Description
Een smartphone-app voor het vastleggen en documenteren van foto's van depigmentatie van de huid.
Screenshots
Pfizer Vitiligo Study B7981019 FAQ
-
Is Pfizer Vitiligo Study B7981019 free?
Yes, Pfizer Vitiligo Study B7981019 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is Pfizer Vitiligo Study B7981019 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does Pfizer Vitiligo Study B7981019 cost?
Pfizer Vitiligo Study B7981019 is free.
-
What is Pfizer Vitiligo Study B7981019 revenue?
To get estimated revenue of Pfizer Vitiligo Study B7981019 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Finland yet.
Ratings History
Pfizer Vitiligo Study B7981019 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
Pfizer Vitiligo Study B7981019 Installs
Last 30 days
Pfizer Vitiligo Study B7981019 Revenue
Last 30 daysPfizer Vitiligo Study B7981019 Revenue and Downloads
Gain valuable insights into Pfizer Vitiligo Study B7981019 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Tissue Analytics
- Languages
- Dutch, English, French, German, Italian, Japanese, Korean, Chinese, Spanish, Chinese
- Recent release
- 2.3 (4 years ago )
- Released on
- Nov 27, 2019 (5 years ago )
- Also available in
- United States , Canada , Russia , Mexico , Malaysia , Netherlands , Norway , New Zealand , Peru , Portugal , Romania , South Korea , Sweden , Singapore , Thailand , Türkiye , South Africa , Kuwait , Argentina , Japan , India , Hong Kong SAR China , United Kingdom , France , Finland , Spain , Egypt , Dominican Republic , Germany , Chile , Switzerland , Australia , Austria
- Last Updated
- 2 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.